We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VRSK:NASDAQVerisk Analytics, Inc. Analysis

Data as of 2026-05-27 - not real-time

$171.50

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Verisk Analytics is trading around $171.5, which sits below its 20‑day SMA (~$172) and well under the 50‑day (~$179) and 200‑day (~$215) averages, confirming a bearish price trend. The RSI at the mid‑40s signals neutral momentum, while the MACD line has crossed above its signal line, generating a bullish histogram that suggests a short‑term bounce may be possible. However, a 30‑day volatility of roughly 39% and a computed beta near -0.13 highlight heightened price swings and a weak correlation to the broader market, raising the overall risk profile. The DCF fair‑value estimate of about $80.8 is dramatically lower than the current market price, implying the stock is substantially overvalued relative to intrinsic fundamentals.
On the fundamentals side, Verisk delivers exceptional profitability with a gross margin near 70% and operating margin above 45%, while revenue is growing modestly at ~4% annually. Free cash flow exceeds $940 million and the dividend yield of 1.17% is supported by a payout ratio under 30%, indicating dividend sustainability. Recent product announcements—including the Model Context Protocol for conversational AI and expanded catastrophe‑risk model access—could unlock new revenue streams, and analyst consensus remains a “Buy” with a mean target near $220, suggesting upside potential if valuation compresses.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram suggests a potential near‑term bounce
  • Price is near the identified support level
  • High short‑term volatility could cause rapid swings

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong profit margins and growing free cash flow
  • Modest revenue growth paired with recurring subscription models
  • Analyst target median price around $220 indicating upside if valuation narrows

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable dividend with low payout ratio
  • Strategic AI‑driven product launches expanding addressable market
  • Resilient business model serving the insurance industry with high barriers to entry

Key Metrics & Analysis

Financial Health

Revenue Growth3.90%
Profit Margin29.34%
P/E Ratio26.1
ROA18.00%
P/B Ratio76.8
Op. Cash Flow$1.4B
Free Cash Flow$944.4M
Industry P/E30.1

Technical Analysis

TrendBearish
RSI47.6
Support$155.94
Resistance$191.51
MA 20$172.24
MA 50$178.88
MA 200$215.09
MACDBullish
VolumeStable
Fear & Greed Index92.34

Valuation

Fair Value$80.76
Target Price$220.47
Upside/Downside28.55%
GradeOvervalued
TypeGrowth
Dividend Yield1.17%

Risk Assessment

Beta-0.13
Volatility39.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.